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Aim: We examined the potential linkage of inflammation to chon- 
drocyte hypertrophy via RAGE-dependent signaling and calgran- 
ulin expression. 
Methods: We studied human OA cartilages in situ, and also stim- 
ulated primary human articular chondrocytes and normal human 
articular chondrocytic CH-8 cells with CXCLS, TNFa, all-trans 
retinoic acid (ATRA) and the calgranulin S100A11. Chondrocyte 
hypertrophy was defined by both type X collagen expression and 
size increase. 
Results: Chondrocyte hypertrophic differentiation develops in OA 
cartilage and promotes dysregulated matrix repair and patho- 
logic calcification that favor disease progression. The Recep- 
tor for Advanced Glycation Endproducts (RAGE) is implicated 
in the pathogenesis of several extraskeletal degenerative disor- 
ders linked to low-grade tissue inflammation and aging. RAGE 
ligands include calgranulin/S100 proteins, which have been re- 
ported to exert cytokine-like ffects. The chemokine IL-8/CXCL8 
stimulates chondrocyte maturation to hypertrophy, and does so 
dependent on both inorganic phosphate uptake and expression of 
TG2, an enzyme that covalently cross-links proteins by transami- 
dation. In this study, the expression of RAGE, and far more ro- 
bustly, $100All ,  were upregulated in OA cartilage. In cultured 
chondrocytes, CXCL8 and TNFa induced $100All expression. 
In turn, recombinant $100All induced chondrocyte hypertro- 
phy, an activity blocked by neutralizing RAGE antibody and sol- 
uble RAGE. $100All induced inorganic phosphate uptake by 
chondrocytes. We observed that not only $100All -  but also 
CXCLS- and TNFa- induced inorganic phosphate uptake were 
RAGE-dependent. Moreover, CXCLS- and TNFa-induced chon- 
drocyte hypertrophy was RAGE-dependent. In contrast, ATRA- 
induced chondrocyte hypertrophy did not require inorganic phos- 
phate uptake or RAGE signaling. Basal expression of the alterna- 
tive calgranulin/S100 receptor CD36 was scarce in cultured chon- 
drocytes. Significantly, transfection of either CD36, or dominant- 
negative RAG E, blocked the capacity of $100A11, I L-8, and TNFa 
to induce collagen expression. The RAGE signal transduction 
chain by which S100A11 induced chondrocyte hypertrophy was 
observed to involve MKK3 (but not MKK4), Racl, p38 MAP Ki- 
nase, and repressed histone deacetylase 4 expression. Last, 
S100A11 activation of RAGE signaling is known to be optimized 
by S100A11 multimerization, which is catalyzed by transglutami- 
nases (TGs). We observed that S100A11-induced chondrocyte 
hypertrophy was attenuated via TG2 knockdown by RNAi, but 
rescued in TG2-deficient chondrocytes by recombinant catalyti- 
cally active TG2. 
Conclusions: In this study we found that RAGE and S100A11 
are upregulated in OA cartilage in situ. RAGE-specific sig- 
naling, triggered by TG2 crosslinked calgranulins including 
S100A11, transduces inflammation-induced chondrocyte hyper- 
trophy. MKK3-specific signaling and inorganic phosphate uptake 
play central roles in RAGE-stimulated chondrocyte hypertrophy. 
Our results reveal novel potential target sites for therapeutic inter- 
vention to disconnect inflammation from chondrocyte dysfunction 
in the course of OA. 
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Introduction: Osteoarthritis (OA) is the result of degradation and 
progressive loss of extracellular matrix (ECM) in articular carti- 
lage. Although the cause of OA is unknown, the chondrocyte 
mediates this process. Type II collagen is degraded by collage- 
nases during the development of OA. MMP-1 and 13 have been 
shown to be present in normal and OA cartilage [1]. It has been 
hypothesized that the degradation products of the collagen can 
be potent signaling molecules and can induce a feedback mech- 
anism in chondrocytes. The aim of this study was to investigate 
the effect of a peptide in the helical domain of type II collagen on 
collagenase expression, activation and production in human OA 
cartilage. 
Materials and Methods: A 24 amino acid synthetic peptide (SP) 
lacking RGD sequence was synthesized by FMOC chemistry. Hu- 
man OA chondroctyes (n=10, age range 55-89) were isolated 
from cartilage obtained from total knee arthoplasty. Chondro- 
cytes were seeded at 1 ×10 6 cells/ml and cultured in the pres- 
ence of DMEM + 10% FCS for 2 days. For simulation studies, 
the chondroctyes were serum starved for 12 hrs and then grown 
in serum-free DMEM. Gene expression for MMPs was analyzed 
by RT-PCR or Real-Time PCR using total RNA extracted from 
chondroctyes. MMP-1, MMP-13 and MMP-14 protein secreted 
into the medium was measured by Western blotting with rabbit 
anti- MMP-1, MMP-13 and MMP-13 antibodies. FAK and PKY2 
activity was measured with anti-FAK and PKY2 antibodies. Anti 
~V and I~1 integrin antibodies were used to block binding of the 
peptide to the respective integrins. Collagenase activity in the cul- 
tures was assayed with incubation of conditioned medium with 
purified pepsinized type II collagen at 25°C for 72 hrs and colla- 
gen cleavage products visualized by SDS-PAGE. 
Results: The SP peptide induced both MMP-1, MMP-13 and 
MMP-14 mRNA in a dose dependant manner. In patients that 
were not expressing MMP-1 or MMP-13, the peptide always in- 
duced their transcription. FAK phosphorylation was also induced 
in a dose dependant manner. There was no induction of PKY2 
phosphorylation by the peptide. Blocking with anti-~V and I~1 in- 
tegrin antibodies did not affect the production of MMP-1 and 13 
induced by the peptide. Collagenase activity also increased with 
the incubation of the peptide in a dose-dependant manner. 
Conclusions: MMP-1 and MMP-13 has been implicated in type 
II collagen degradation in OA cartilage. This cleavage results in 
production of collagen degradation fragments that can feedback 
and further activate MMPs. We have shown that a helical peptide 
of type II collagen can stimulate the production and activation of 
both MMP-1 and MMP-13 in OA chondrocytes. MMP-14 was also 
stimulated and may be responsible for the activation of the MMP- 
1 and MMP-13 produced by the OA chondrocytes. Further study 
into the signaling of this peptide and its role in MMP-1 and MMP- 
13 transcription, synthesis and activation could provide more tar- 
gets for blocking type II collagen degradation in OA patients. 
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